BUCLIZINE HYDROCHLORIDE (byoo-cli'zeen) Bucladin-S Softab Classifications: antihistamine; antivertigo Prototype: Meclizine Pregnancy Category: C |
50 mg tablets
A piperazine derivative structurally and pharmacologically related to meclizine and cyclizine. Mechanism of action not precisely known but may be related to its central anticholinergic actions. It diminishes vestibular stimulation and depresses labyrinthine function. Action on the medullary chemoreceptive trigger zone (CTZ) may also be involved in its antiemetic effect.
Exhibits antihistaminic, anticholinergic, antivertigo, CNS depressant, and local anesthetic effects.
Prevention and treatment of motion sickness and the symptomatic treatment of vertigo.
Hypersensitivity to buclizine hydrochloride, children <2 y, older adults, pregnancy (category C), lactation, Reye's syndrome.
Patients also receiving other CNS depressants or depressant drugs; angle-closure glaucoma; prostatic hypertrophy; bladder neck obstruction; pyloroduodenal obstruction.
Motion Sickness Adult: PO 50 mg 30 min before travel, may repeat in 46 h if needed Vertigo Adult: PO 50 mg 13 times/d |
May interfere with allergy skin tests.
Assessment & Drug Effects
Patient & Family Education